Manus Donahue, MBA, PhD

Manus J. Donahue, MBA, PhD is a Professor of Neurology within the Division of Cognitive and Behavioral Neurology and serves as Assistant Vice Chair for Research. Dr. Donahue trained at Duke University (BS: Physics; BA: Philosophy), The Johns Hopkins School of Medicine (PhD: Biophysics), and the University of Oxford (post-doc: Neurology). He joined the Johns Hopkins faculty in 2009 and in 2010 moved to Vanderbilt University Medical Center, where he is currently a Professor of Neurology. His work is focused on using new imaging and computational approaches to characterize tissue function in health and disease and he has led NIH-funded trials whereby these approaches have been applied in patients with atherosclerotic cerebrovascular disease, moyamoya disease and syndrome, sickle cell disease, neurodegeneration (Parkinson’s disease and Alzheimer’s disease), and peripheral lymphatic disorders to evaluate emerging therapies. He is Chair of the Vanderbilt Human Subjects Protections Committee (HS2), editorial board member for the Journal of Cerebral Blood Flow and Metabolism, member of the FDA-initiated Brain panel to determine endpoints in clinical trials of sickle cell disease, and chief executive officer of Biosight, LLC which operates as a clinical research organization.